Advanced Lung Cancer Inflammation Index Predicts Outcomes Of Patients With Colorectal Cancer After Surgical Resection

BACKGROUND: The advanced lung cancer inflammation index is considered a useful prognostic biomarker of clinical outcomes in patients with malignancies. However, the prognostic value of the advanced lung cancer index in patients with colorectal cancer who underwent surgical resection remains unclear.OBJECTIVE: In this study, we evaluated the prognostic value of the advanced lung cancer index in patients with colorectal cancer.DESIGN: Prospectively obtained data of patients with colorectal cancer were retrospectively evaluated to clarify the clinical relevance of the advanced lung cancer index.SETTINGS: We conducted this study at a single expert center.PATIENTS: We enrolled 298 patients with colorectal cancer who underwent surgical resection in this retrospective study.MAIN OUTCOME MEASURES: The primary outcome was the clinical relevance of the advanced lung cancer index in patients with rectal cancer.RESULTS: Low status of advanced lung cancer index was significantly correlated with undifferentiated histology (p= 0.004), T stage progression (p< 0.001), R1/R2 resection for primary surgery (p= 0.004), and distant metastasis (p< 0.001). Multivariate analysis showed that low advanced lung cancer index status was an independent prognostic factor for both overall survival (HR = 3.21 (95% CI, 1.97-5.19);p< 0.001) and disease-free survival (HR = 2.13 (95% CI, 1.23-3.63);p= 0.008) in patients with colorectal cancer. Furthermore, the clinical burden of the advanced lung cancer index was consistent between sexes, and its prognostic value was verified in patients with clinically relevant stage III colorectal cancer.LIMITATIONS: The present study had several limitations, including retrospective observation and a small sample size of Japanese patients from a single institution.CONCLUSIONS: The advanced lung cancer index could be a useful prognostic indicator of clinical outcomes in patients who underwent surgical resection for colorectal cancer.